- Home
- PAVS vs UNCY Comparison
PAVS vs UNCY Comparison
Compare PAVS & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- UNCY
- Stock Information
- Founded
- PAVS 2004
- UNCY 2016
- Country
- PAVS United States
- UNCY United States
- Employees
- PAVS N/A
- UNCY N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- PAVS Health Care
- UNCY Health Care
- Exchange
- PAVS Nasdaq
- UNCY Nasdaq
- Market Cap
- PAVS 89.6M
- UNCY 71.8M
- IPO Year
- PAVS 2019
- UNCY 2021
- Fundamental
- Price
- PAVS $1.33
- UNCY $0.60
- Analyst Decision
- PAVS
- UNCY Strong Buy
- Analyst Count
- PAVS 0
- UNCY 2
- Target Price
- PAVS N/A
- UNCY $5.25
- AVG Volume (30 Days)
- PAVS 6.8K
- UNCY 1.2M
- Earning Date
- PAVS 01-01-0001
- UNCY 05-12-2025
- Dividend Yield
- PAVS N/A
- UNCY N/A
- EPS Growth
- PAVS N/A
- UNCY N/A
- EPS
- PAVS N/A
- UNCY N/A
- Revenue
- PAVS $6,544,819.00
- UNCY N/A
- Revenue This Year
- PAVS N/A
- UNCY N/A
- Revenue Next Year
- PAVS N/A
- UNCY $1,677.16
- P/E Ratio
- PAVS N/A
- UNCY N/A
- Revenue Growth
- PAVS N/A
- UNCY N/A
- 52 Week Low
- PAVS $0.32
- UNCY $0.20
- 52 Week High
- PAVS $1.50
- UNCY $1.29
- Technical
- Relative Strength Index (RSI)
- PAVS 43.14
- UNCY 54.18
- Support Level
- PAVS $1.29
- UNCY $0.45
- Resistance Level
- PAVS $1.40
- UNCY $0.63
- Average True Range (ATR)
- PAVS 0.05
- UNCY 0.06
- MACD
- PAVS -0.00
- UNCY 0.01
- Stochastic Oscillator
- PAVS 66.67
- UNCY 78.95
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.